We are live on
!
Find out more
LP
LMR Partners Portfolio holdings
AUM
$45.4B
1-Year Est. Return
60.68%
This Fund
S&P 500
This Quarter
Est. Return
+23.27%
1 Year Est. Return
+60.68%
3 Year Est. Return
+183.94%
5 Year Est. Return
+215.13%
10 Year Est. Return
+663.15%
AUM
$11.9B
AUM Growth
-$665M
(-5.3%)
Cap. Flow
-$2.07B
Cap. Flow
% of AUM
-17.42%
Top 10 Holdings %
Top 10 Hldgs %
29.25%
Holding
1,790
New
534
Increased
200
Reduced
243
Closed
613
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$472M |
| 2 |
EDR
Endeavor Group Holdings, Inc.
EDR
|
+$63M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$61M |
| 4 |
FYBR
Frontier Communications
FYBR
|
+$56.7M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$43.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$107M |
| 2 |
GSK
GSK
|
+$58.9M |
| 3 |
Broadcom
AVGO
|
+$54M |
| 4 |
Unilever
UL
|
+$54M |
| 5 |
Marvell Technology
MRVL
|
+$48.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.5% |
| 2 | Communication Services | 3.61% |
| 3 | Financials | 3.6% |
| 4 | Healthcare | 3.01% |
| 5 | Consumer Discretionary | 1.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
PUT
American International
AIG
$42B
| $2.26M | 0.02% |
31,100
-14,100
| -31% | -$1.06M |
|
|
VRNA
527
CALL
DELISTED
Verona Pharma
VRNA
| $2.25M | 0.02% |
+48,500
| New | +$1.82M |
|
528
CALL
Akamai
AKAM
$16.4B
| $2.25M | 0.02% |
23,500
| – | – |
|
529
PUT
Novavax
NVAX
$1.23B
| $2.22M | 0.02% |
276,400
-373,200
| -57% | -$3.6M |
|
530
Biogen
BIIB
$29.5B
| $2.22M | 0.02% |
14,500
+6,379
| +79% | +$1.08M |
|
531
CALL
Air Products & Chemicals
APD
$65.2B
| $2.2M | 0.02% |
7,600
+1,100
| +17% | +$345K |
|
532
CALL
Seagate
STX
$185B
| $2.2M | 0.02% |
25,500
| – | – |
|
533
CALL
Coupang
CPNG
$28.6B
| $2.2M | 0.02% |
+100,000
| New | +$2.45M |
|
534
Legend Biotech
LEGN
$3.73B
| $2.19M | 0.02% |
67,200
-57,200
| -46% | -$2.37M |
|
535
PUT
Summit Therapeutics
SMMT
$10.5B
| $2.17M | 0.02% |
121,800
+21,800
| +22% | +$423K |
|
536
CALL
Comcast
CMCSA
$80.9B
| $2.16M | 0.02% |
57,600
| – | – |
|
537
Surgery Partners
SGRY
$1.98B
| $2.16M | 0.02% |
+101,800
| New | +$2.67M |
|
538
PUT
Dollar General
DG
$27.2B
| $2.15M | 0.02% |
+28,400
| New | +$2.24M |
|
539
Datadog
DDOG
$89.7B
| $2.15M | 0.02% |
+15,054
| New | +$2.07M |
|
|
NVO
540
Novo Nordisk
NVO
$220B
| $2.15M | 0.02% |
24,999
-38,534
| -61% | -$4.17M |
|
|
541
PUT
Datadog
DDOG
$89.7B
| $2.14M | 0.02% |
15,000
-12,600
| -46% | -$1.73M |
|
542
PUT
Wynn Resorts
WYNN
$10.3B
| $2.14M | 0.02% |
24,800
| – | – |
|
543
CALL
Abbott
ABT
$182B
| $2.13M | 0.02% |
18,800
| – | – |
|
544
ServiceNow
NOW
$109B
| $2.12M | 0.02% |
10,000
-26,895
| -73% | -$5.45M |
|
545
PUT
United Rentals
URI
$70.2B
| $2.11M | 0.02% |
3,000
| – | – |
|
546
PUT
Nutanix
NTNX
$15.4B
| $2.11M | 0.02% |
34,500
+31,400
| +1,013% | +$2.05M |
|
547
PUT
Celsius Holdings
CELH
$7.36B
| $2.11M | 0.02% |
+80,000
| New | +$2.37M |
|
548
CALL
Cigna
CI
$77B
| $2.1M | 0.02% |
7,600
| – | – |
|
549
PUT
Capricor Therapeutics
CAPR
$405M
| $2.09M | 0.02% |
151,800
| – | – |
|
550
VanEck Oil Services ETF
OIH
$2.06B
| $2.09M | 0.02% |
+7,700
| New | +$2.21M |
|
Similar funds
AS
TI
LMR Partners's Q4 2024 Portfolio in Review
As of Q4 2024, LMR Partners held 1,790 positions worth $11.9B, down 5.3% from $12.6B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
LMR Partners withdrew a net $2.07B in Q4 2024, closing 613 positions and reducing 243 holdings. Its most notable exit was Unilever, an estimated $54M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 10% a quarter earlier, followed by Communication Services and Financials.
Against the trend, LMR Partners opened a new position in Vertex Pharmaceuticals worth $37.8M.
- LMR Partners's largest Q4 2024 buy was Vertex Pharmaceuticals: 93,801 shares worth $37.8M.
- LMR Partners added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $472M increase.
- LMR Partners's biggest Q4 2024 reduction was TSMC, cutting an estimated $107M.
- LMR Partners fully exited Unilever in Q4 2024, selling an estimated $54M.
- LMR Partners's ten largest holdings make up 29% of its $11.9B portfolio in Q4 2024.
- LMR Partners opened 534 new positions and closed 613 in Q4 2024.
- LMR Partners's portfolio value fell 5.3% quarter-over-quarter to $11.9B.
Based on LMR Partners's 13F filing for Q4 2024, filed 14 Feb 2025.